Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedUpdate of the Italy location entry from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded a new resource entry for Cutaneous neuroendocrine carcinoma under the Genetic and Rare Diseases Information Center resources in the study page.SummaryDifference0.1%

- Check19 days agoChange DetectedReplaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the locations section.SummaryDifference0.0%

- Check26 days agoChange DetectedA new revision tag v3.5.0 was added, replacing the previous v3.4.3.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 removed. This is a minor UI/versioning update that does not alter study details or user-facing content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.2 was added, while the prior Revision: v3.4.1 and a government funding/operating status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.